Navigation Links
Mission Pharmacal Celebrates Historic Milestone
Date:2/2/2009

Pioneer in Women's Health Marks 64 Years of Innovation and Growth

SAN ANTONIO, Feb. 2 /PRNewswire/ -- Mission Pharmacal Company this year celebrates 64 years of excellence in manufacturing and distributing pharmaceutical products primarily for women's health. For more than six decades, Mission Pharmacal has enhanced the quality of consumers' lives through innovative, science-based, quality pharmaceutical products, vitamins and supplements.

Founded in 1945 by H.N. Walsdorf, a pharmacist, the Texas-based company was built on the philosophy that most existing pharmaceutical formulations had the potential to be more effective and better tolerated. Three generations later, Neill B. Walsdorf, Jr. carries on the traditions of quality and value established by his grandfather and continued by his father.

"We are honored to celebrate 64 years in the pharmaceutical industry," said Neill Walsdorf, Jr., president of Mission Pharmacal. "We recognize this achievement and will continue my grandfather's mission to provide breakthrough products and the level of quality that has been associated with the Mission name. In addition to our expertise in current therapeutic areas, we will look to developments in new areas of osteoporosis, urolithiasis and cardiovascular disease."

The company has a broad portfolio of over-the-counter and prescription products that enhance prenatal nutrition, treat parasitic and bacterial infections, prevent kidney stone recurrence and help relieve arthritis and muscle pain. Major brands include the CitraNatal(R) family of prescription prenatal vitamins, designed to support pregnant women's comfort with calcium citrate and other well-tolerated ingredients while optimizing nutrition for their babies' growth and development; Ferralet(R) 90, for iron deficiency anemia, that transforms prescription oral iron therapy into a gentle experience with carbonyl iron; Tindamax(R) (tinidazole), the only oral antimicrobial approved for the treatment of both trichomoniasis and bacterial vaginosis (as well as many other bacterial infections) and Urocit-K(R), a formulation of potassium citrate used to treat nephrolithiasis in people with kidney stones that is the standard treatment in its category.

About Mission Pharmacal Company

Mission Pharmacal is a privately held pharmaceutical company based in San Antonio, Texas. For more than 60 years, Mission has been committed to meeting the unique needs of women throughout all stages of life, identifying unmet health needs in the marketplace, and developing innovative prescription and over-the-counter products to meet them. Currently, Mission Pharmacal provides physicians and consumers with pharmaceutical and nutritional products. For more information on Mission, visit www.missionpharmacal.com.


'/>"/>
SOURCE Mission Pharmacal Company
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Watson Acknowledges Federal Trade Commission Action Regarding AndroGel Patent Settlement
2. Light Sciences Oncology Elects Former FDA Commissioner Frank Young, M.D., Ph.D., to Board of Directors
3. Sierra Tucson Achieves Hospital Accreditation, Now Holds Dual Accreditation by the Joint Commission
4. Surveyed Gastroenterologists Indicate That Humira Has Advantages Over Remicade in Maintaining Clinical Remission of Crohns Disease
5. Fairview Baptist Home Selects PatientPlacement.com to Automate Referrals and Increase Patient and Resident Admissions
6. EliteMeetings.com Announces Commission-Free Policy Comprehensive Search and RFP Engine Now Provides Net Rates for Groups
7. In Time, Cream Might Prevent Herpes Transmission
8. Pennsylvania Insurance Commissioner Welcomes U.S. House Vote to Reauthorize Childrens Health Care
9. One Mans Determined Journey to Remission and a Renewed Sense of Faith
10. Particulate Emission from Natural Gas Burning Home Appliances Is Assessed in Environmental Engineering Science Journal
11. Kansas Insurance Commissioner, Sandy Praeger, to Appear this Saturday on Cary Hall's Health Insurance Advocate Radio Show
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... ... May 02, 2016 , ... This week Omega Institute, a ... guest season which runs through October. Omega is offering a record 370 in-person workshops ... “There has never been such widespread interest in or need for the knowledge and ...
(Date:5/2/2016)... ... 02, 2016 , ... Dr. Rassouli, dentist in Orange County, CA ... the research, which was published in the “Journal of the American Geriatrics Society,” more ... million Americans have Alzheimer’s disease. The study found that dental problems may increase the ...
(Date:5/2/2016)... RICHEY, Fla. (PRWEB) , ... ... ... and medical researchers report that many commonly used prescription medications, including anxiolytics, ... (1). To mitigate these risks, Novus Medical Detox Center —a leading ...
(Date:5/2/2016)... , ... May 02, 2016 , ... ... (AAC) event, will be held at the Bellagio Hotel in Las Vegas, NV ... Social Work (NASW) will be co-hosting the event. , This year’s conference will ...
(Date:5/2/2016)... ... May 02, 2016 , ... Consultative health care market research ... Callandrillo and Duane Reed, VP of business development of AJMC Strategic Solutions, will ... Group (PBIRG) General Meeting from May 15-17 at the Boca Raton Resort ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... April 28, 2016 Oramed Pharmaceuticals Inc. ... pharmaceutical company focused on the development of oral drug delivery ... upcoming PIONEERS 2016 conference, presented by Joseph Gunnar ... New York . Nadav Kidron , ... conference. Presentation Details:   PIONEERS ...
(Date:4/27/2016)... Inc. (Nasdaq: HOLX ) announced today ... quarter ended March 26, 2016.  GAAP diluted earnings ... non-GAAP diluted EPS of $0.47 increased 14.6%.  Revenue ... basis, and 6.3% on a constant currency basis.  ... highlighted by 14.6% growth in non-GAAP EPS," said ...
(Date:4/27/2016)... York , April 27, 2016 ... report titled, "Skincare Devices Market - Global Industry Analysis, ... According to the report, the global skincare devices market ... is anticipated to expand at a CAGR of 10.1% ... in 2023. Browse the full Skincare Devices Market ...
Breaking Medicine Technology: